UPDATE: Oppenheimer Downgrades Body Central to Perform on on Lower Q4 Guidance

Oppenheimer downgraded Body Central Corp. BODY from Outperform to Perform. Oppenheimer noted, "This morning, ahead of its participation at the ICR XChange Conference this Wednesday, January 16th, at 9:25 AM, BODY lowered 4Q EPS guidance to $0.10 (from $0.19-$0.22) and vs. Opco/consensus estimates of $0.28/$0.23. December proved to be especially challenging at the expense of margins and the turnaround is now taking longer to gain traction than initially expected. While we have confidence in the LT fundamentals and initiatives in place to support growth, we are stepping to the sidelines until we gain further visibility. Downgrading to Perform from Outperform and rescinding our price target." Body Central closed at $9.71 on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorDowngradesIntraday UpdateAnalyst RatingsOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!